Qi Liu

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

S. Leavitt, T. Appleby, M. Fenaux, 2012, Antimicrobial Agents and Chemotherapy.

Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection.

S. Leavitt, T. Appleby, M. Fenaux, 2014, Journal of medicinal chemistry.

Structural and Binding Analysis of Pyrimidinol Carboxylic Acid and N-Hydroxy Quinazolinedione HIV-1 RNase H Inhibitors

Xiaohong Liu, S. Leavitt, M. Balakrishnan, 2011, Antimicrobial Agents and Chemotherapy.

Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors.

W. Zhong, G. Cheng, Xubin Zheng, 2011, ACS medicinal chemistry letters.

RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.

Xiaohong Liu, S. Leavitt, J. Mak, 2009, Journal of medicinal chemistry.

Clinical targeting of HIV capsid protein with a long-acting small molecule

J. R. Somoza, W. Sundquist, Xiaohong Liu, 2020, Nature.

Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection.

T. Appleby, M. Fenaux, Xiaowu Chen, 2014, Journal of medicinal chemistry.